Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma is an uncurable hematological malignancy, although the prognosis of myeloma patients is getting better using proteasome inhibitors (PIs), immune modulatory drugs (IMiDs), monoclonal antibodies (MoAbs), and cytotoxic agents. Drug resistance makes myeloma difficult to...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kazuhito, Nishiwaki, Kaichi, Yano, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827913/
https://www.ncbi.nlm.nih.gov/pubmed/33435539
http://dx.doi.org/10.3390/cancers13020215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827913/
https://www.ncbi.nlm.nih.gov/pubmed/33435539
http://dx.doi.org/10.3390/cancers13020215

Ejemplares similares